IDEXX Laboratories Announces Third Quarter Results

Achieves third quarter revenue growth of 9% reported and 8% organic, driven by CAG Diagnostics recurring revenue growth of 10% reported and 9% organic



Solid revenue growth reflects benefits from...

Related Keywords

Japan ,United Kingdom ,Maine ,United States ,Canada ,China ,Australia ,Brazil ,Chinese ,Brazilian ,Australian ,Japanese ,America ,British ,Canadian ,Jay Mazelsky ,Foreign Currency Exchange Rate Impacts ,Company Quarterly Reports On Form ,Forward Foreign Currency Exchange Rate Assumptions ,Nasdaq ,Laboratories Inc ,Companion Animal Group ,Service Categories ,Company Annual Report On Form ,Exchange Commission ,Chief Executive ,Financial Performance ,Recurring Revenue ,Private Securities Litigation Reform Act ,Financial Condition ,Qualitative Disclosures About Market ,Annual Report ,Quarterly Reports ,Financial Performance Outlook ,Compensation Stock ,Employee Share Based Payment Accounting ,Leverage Ratios ,Quarterly Report ,Consolidated Statement ,Operating Information ,Revenue Growth Analysis ,Statements Regarding ,Balance Sheet Information ,Operating Activities ,Investing Activities ,Financing Activities ,Cash Flow ,Markets ,